Peptide Plug

Age Verification

Peptide Plug is a research and organization tool intended for adults 18 years of age or older. By continuing, you confirm you are at least 18.

Reference only · Not medical advice · For adults 18+ · No dosing information is published here
Peptide Plug
HomeResearchEducationToolsGuidesCompareAboutOpen the App
Home/Research library/CJC-1295 / Ipamorelin Blend
Growth Hormone

CJC-1295 / Ipamorelin Blend — reference

Combined GH-secretagogue stack.

Regulatory statusNot FDA-Approved
Published half-lifeReflects both components (~30min CJC no-DAC, ~2h ipamorelin)
Evidence levelPK study
CategoryGrowth Hormone

Regulatory status

Not FDA-Approved. Not FDA-approved.

Reported cautions

⚠ Worth knowing. Both components raise IGF-1, so effects add rather than overlap. Water retention, joint aches and carpal-tunnel symptoms are the usual signs of too much. Ratios differ between suppliers. Banned by WADA.

Pharmacokinetics

Published figures give an elimination half-life of Reflects both components (~30min CJC no-DAC, ~2h ipamorelin). Assumes no-DAC CJC — check which CJC variant is actually in the blend.

This figure is tagged PK study in our evidence system. This figure comes from a published pharmacokinetic study rather than a label or registration trial. Sample sizes in such studies are often small and figures vary between them, so treat the number as a range rather than a constant. You can see the shape this implies between doses in the Half-Life Visualizer, and compare it against every other compound in the Half-Life Data Table. Our sourcing page explains what each tier means.

Remember that an estimated curve is a model built from a population figure, not a measurement of your blood. Individual clearance varies, and for depot injections the figure describes release from the injection site rather than the compound clearing. Half-life explained →

What Peptide Plug does and does not publish

This page carries regulatory status, general context and published pharmacokinetics. It carries no dose, frequency or cycle information — that is a deliberate editorial line, because dosing is a clinical decision rather than reference data. We also do not sell, supply, source or link to vendors for any compound.

Frequently asked

Is CJC-1295 / Ipamorelin Blend FDA-approved?
Not FDA-Approved. Not FDA-approved.
What is the half-life of CJC-1295 / Ipamorelin Blend?
Published figures give Reflects both components (~30min CJC no-DAC, ~2h ipamorelin). Assumes no-DAC CJC — check which CJC variant is actually in the blend.
How reliable is that half-life figure?
It is tagged “PK study” in our system. This figure comes from a published pharmacokinetic study rather than a label or registration trial. Sample sizes in such studies are often small and figures vary between them, so treat the number as a range rather than a constant.
What cautions are associated with CJC-1295 / Ipamorelin Blend?
Both components raise IGF-1, so effects add rather than overlap. Water retention, joint aches and carpal-tunnel symptoms are the usual signs of too much. Ratios differ between suppliers. Banned by WADA.
Does Peptide Plug publish dosing for CJC-1295 / Ipamorelin Blend?
No. This library publishes regulatory status, general context and pharmacokinetics only. Dose, frequency and cycle information is deliberately absent from these public pages — those are clinical decisions, not reference data.
Does Peptide Plug sell CJC-1295 / Ipamorelin Blend?
No. We do not sell, supply, source or link to vendors for any compound, and we have no affiliate arrangements with suppliers. Peptide Plug is a tracking and calculation tool.

Related tools

Free, no account required.

TRT Dose Calculator
Weekly target split across injections.
Free Testosterone Calculator
Vermeulen estimate from labs.
Half-Life Visualizer
Estimated rise-and-fall curve between doses.
Reconstitution Calculator
Vial math including blend support.
Medication Storage Calculator
Discard windows from published guidance.
Half-Life Data Table
All 86 compounds with evidence tags.
Pro Protocol Reference

The public research page intentionally does not publish dosing. Pro subscribers can open the separate Protocol Library for structured indication, frequency, duration, notes, and review-first Cycle Builder import when a matching reference is available.

View Protocol Reference
Reference information, not medical advice. This page describes regulatory status and published pharmacokinetics. It does not tell you whether to use this compound, how much to use, how often, or whether it is safe for you. Peptide Plug does not sell, supply or source any compound. Those decisions belong to you and a licensed clinician.

Part of the Peptide Plug research library · How we source our figures · All compounds A–Z